BioLargo, Inc.
corporate_fare Company Profile
BioLargo, Inc. (OTC:BLGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for BLGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 8/10. Across its 11 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for BLGO spans 10-Q, 8-K, 10-K/A.
Recent high-impact activity:
- BioLargo Q2 2026: Revenue Plunges 61%, Going Concern Warning Reiterated
- BioLargo Q1 Revenue Plummets 66% to $1.12M, Net Loss Widens Significantly
- BioLargo Reports 66% Revenue Drop, Going Concern Warning, and Material Weakness Amid Dilutive Financing
- BioLargo CEO Details Strategic Partnerships, Major Contracts, and Commercialization Progress Across Subsidiaries
- Exclusive Distribution Deal Expands ViaCLYR™ Reach to 500M People in MENA
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,020 shares in BLGO as of the September 15, 2026 settlement, a 88.6% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 39.5% of BLGO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.